Medtronic Cardiac Ablation Solutions Clinical Trials
Sponsors / Medtronic Cardiac Ablation Solutions
Medtronic Cardiac Ablation Solutions appears as lead sponsor on 31 trial records in ClinicalTrials.gov. The portfolio currently includes 10 recruiting studies, 1 active non-recruiting studies, and 17 completed studies. 2 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include regulatory actions, slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 15,845 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
31
Total Trials
10
Recruiting
1
Other Active
17
Completed
2
Terminated / Withdrawn
15,845
Total Enrollment
Termination reasons: Regulatory50% · Recruitment50%
Recent Terminations
- NCT05230524 Stopped Dec 2025Paroxysmal Atrial Fibrillation"Sponsor and FDA agreed on early termination."
- Persistent Atrial Fibrillation"The study was stopped solely based on lower than expected enrollment rate."
Active Trials (1 total)
- NCT06703489
- NCT07308847
- NCT05115214
- NCT05144503
- NCT06393920
- NCT06578104
- NCT04735016
- NCT06858306
- NCT05005949
- NCT05227053
- NCT06026345
Top Conditions
Atrial fibrillation (17) Paroxysmal atrial fibrillation (3) Persistent atrial fibrillation (3) Arrhythmia (1) Atrial fibrillation (af) (1) Atrial fibrillation, bradycardia (1) Atrioventricular nodal reentrant tachycardia (1) Paroxysmal af (1) Paroxysmal atrial fibrillation (paf) (1) Symptomatic paroxysmal atrial fibrillation without clinically significant heart diseases (1)